Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 676-700 of 958 matching filings.

Per page
25
Current page
28
DEFA14A File 001-36066

FORM 8-K

Filing date
13 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
13 Nov 2013
Reporting date
08 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36066

DEFA14A

Filing date
07 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
07 Nov 2013
Reporting date
04 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
07 Nov 2013
Reporting date
07 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Nov 2013
Reporting date
04 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Oct 2013
Reporting date
28 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
28 Oct 2013
Reporting date
24 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
PREC14A File 001-36066

PREC14A

Filing date
18 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Oct 2013
Reporting date
07 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

TRANSCEPT SCHEDULE 13D/A 10-7-13

Filing date
07 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
07 Oct 2013
Reporting date
07 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36066

FORM 8-K

Filing date
07 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

SCHEDULE 13D/A

Filing date
04 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

TRANSCEPT SCHEDULE 13D/A 10-3-13

Filing date
03 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
30 Sep 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Sep 2013
Reporting date
25 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
25 Sep 2013
Reporting date
25 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
25 Sep 2013
Reporting date
25 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
25 Sep 2013
Reporting date
25 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

SCHEDULE 13D/A 9-19-13

Filing date
19 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Sep 2013
Reporting date
17 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-36066

FORM 8-A

Filing date
13 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .